infections

Documents about infections

• 42 U.S.C. § 247b-15 — Surveillance and education regarding infections associated with illicit drug use and other risk factors#595378US Code (LII)
• Post-marketing Surveillance Study With GSK Biologicals' Pneumococcal Vaccine in Healthy Infants in Philippines#18696ClinicalTrials.gov
• Lot Consistency, Immuno, Safety of Meningococcal Vaccine GSK134612 Given With Fluarix™ to 18-55 Year-Old Adults#18716ClinicalTrials.gov
• Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis#28350ClinicalTrials.gov
• Bovine Colostrum for Prophylaxis Against Recurrent Urinary Tract Infection in Children#28378ClinicalTrials.gov
• Safety of Purified Meningococcal Vaccine With Serogroups ACWY, in 3,000 Filipino Subjects Aged > 2 Years#28397ClinicalTrials.gov
• Primary Vaccination Course in Children Receiving the Pneumococcal Vaccine GSK 1024850A, Zilbrix™ Hib and Polio Sabin™#28412ClinicalTrials.gov
• Long-term Efficacy and Safety of Subjects Approximately 3 Years After Priming With 2 Doses of GSK Bio's HRV Vaccine.#67667ClinicalTrials.gov
• Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Human Papillomavirus (HPV) Vaccine (GSK-580299) and Merck's Gardasil Vaccine When Administered According to Alternative 2-dose Schedules in 9-14 Year Old Females#67673ClinicalTrials.gov
• Study of 2 Doses of Oral Live Attenuated Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis#67681ClinicalTrials.gov
• Safety and Immunogenicity of an Aluminium Hydroxide/LHD153R Adjuvanted Meningococcal C-CRM197 Conjugate Vaccine#67688ClinicalTrials.gov
• Evaluate 4 Different Formulations of Meningococcal Serogroups A, C, W-135, Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 Yrs#67693ClinicalTrials.gov
• A Single Oral Escalating Dose Study of GSK2140944 in Healthy Volunteers#67953ClinicalTrials.gov
• Susceptibility to Infectious Diseases in obEsity: an endocRine trAnslational socioLogic Evaluation, "SIDERALE"#121402ClinicalTrials.gov
• Rural Hospital-Level Care at Home for Acutely Ill Adults#121415ClinicalTrials.gov
• A Study in Elderly Subjects With Pneumonia to Support the Development of Bacteriological Diagnostic Assays#121453ClinicalTrials.gov
• Plasma Protein Binding and PK/PD of Total and Unbound Temocillin Non-ICU Patients#123485ClinicalTrials.gov
• Detection of Pathogen and Antibiotic Resistance Genes by Targeted Next-Generation Sequencing in ICU Patients.#123512ClinicalTrials.gov
• Dose-Ranging Study of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections#123525ClinicalTrials.gov
• To Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants in Co-administration With Specific Childhood Vaccines#123536ClinicalTrials.gov
• Study to Assess the Immunological Long-term Persistence of Antibodies (Abs) 2 Years After GlaxoSmithKline (GSK) Meningococcal ABCWY Vaccination in the V102_15 (NCT02212457) and Response to a Booster in Adolescents#123548ClinicalTrials.gov
• Immunogenicity and Safety Study of GSK Biologicals' Human Papillomavirus 580299 Vaccine in Healthy Female Subjects#123553ClinicalTrials.gov
• Complementary Testing to Evaluate Immunogenicity of Human Papillomavirus (HPV) Vaccine (580299) in Healthy Female Subjects Aged >/= 26 Years#123574ClinicalTrials.gov
• A Study in Infants to Test Two Preparations (Freeze-dried or Liquid) of the Rotavirus Vaccine (HRV Vaccine).#329588ClinicalTrials.gov
• Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine Given as One Dose to Healthy Subjects Above 56 Years#329589ClinicalTrials.gov
• Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine#343694ClinicalTrials.gov
• Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future#343750ClinicalTrials.gov
• A Single Center Four Part Study in Healthy Adult Subjects to Evaluate: the Safety, Tolerability and Pharmacokinetics of a Single Oral Dose and Repeat Escalating Oral Doses of GSK945237; the Effect of Linezolid on Hematology Safety Parameters; and the Effects of GSK945237 and Moxifloxacin on QTc.#343854ClinicalTrials.gov
• Cervarix Long-term Safety Surveillance#346871ClinicalTrials.gov
• Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus Vaccine With Another Vaccine in Healthy Female Subjects#346968ClinicalTrials.gov
• Assess the Immunogenicity of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine#346977ClinicalTrials.gov
• Safety & Immunogenicity of Pneumococcal Vaccine 2189242A in Children Aged 12-23 Months at the Time of First Vaccination#346992ClinicalTrials.gov
• The Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study#350015ClinicalTrials.gov
• Study to Assess Immune Responses and Safety of the GSK-580299 Vaccine in Healthy Women (26 to 45 Years)#353326ClinicalTrials.gov
• Evaluation of the Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine in Young Males.#363646ClinicalTrials.gov
• Drug Use Investigation for Cervarix®#363658ClinicalTrials.gov
• Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study#366640ClinicalTrials.gov
• ABO-incompatible kidney transplantation: impact of apheresis on graft and patient survival in recipients with low isoagglutinin titer#284396HAL (France)

Related topics